Norges Bank Cytokinetics Inc Transaction History

Norges Bank

$736 Billion
Q4 2024

A detailed history of Norges Bank transactions in Cytokinetics Inc stock. As of the latest transaction made, Norges Bank holds 989,721 shares of CYTK stock, worth $41.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

989,721

Holding current value

$41.1 Million

% of portfolio

0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$46.36 - $58.62 $45.9 Million - $58 Million	989,721 New	989,721 $46.6 Million
Q2 2024 Aug 14, 2024	BUY	$47.86 - $75.05 $38.3 Million - $60 Million	799,664 New	799,664 $43.3 Million
Q4 2023 Feb 09, 2024	BUY	$26.88 - $83.49 $19.4 Million - $60.3 Million	722,229 New	722,229 $60.3 Million
Q3 2023 Nov 13, 2024	BUY	$29.46 - $36.61 $24.4 Million - $30.4 Million	829,507 New	829,507 $24.4 Million
Q3 2023 Nov 13, 2023	SELL	$29.46 - $36.61 $24.3 Million - $30.1 Million	-823,496 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$32.62 - $40.75 $1.57 Million - $1.96 Million	-48,214 Reduced 6.03%	751,450 $24.5 Million
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $24.6 Million - $30.7 Million	-752,734 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$33.36 - $45.71 $24.6 Million - $33.7 Million	738,159 New	738,159 $26 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $30 Million - $42.9 Million	839,356 New	839,356 $38.5 Million
Q3 2022 Nov 13, 2023	BUY	$38.54 - $54.52 $31.7 Million - $44.9 Million	823,496 New	823,496 $39.9 Million
Q2 2022 Aug 14, 2023	BUY	$33.93 - $48.92 $25.5 Million - $36.8 Million	752,734 New	752,734 $29.6 Million
Q1 2022 May 12, 2023	SELL	$29.74 - $46.0 $7.23 Million - $11.2 Million	-242,977 Reduced 28.95%	596,379 $22 Million
Q4 2020 Feb 10, 2021	SELL	$15.26 - $28.61 $3.16 Million - $5.93 Million	-207,200 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$20.58 - $28.96 $4.26 Million - $6 Million	207,200 New	207,200 $4.49 Million
Q3 2020 Nov 10, 2020	SELL	$20.58 - $28.96 $4.26 Million - $6 Million	-207,200 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$11.15 - $24.64 $2.31 Million - $5.11 Million	207,200 New	207,200 $4.88 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.55M

Put Options Held

2.42M

Black Rock Inc. New York, NY

14.7M
Shares

$610 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

11.9M
Shares

$495 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

9.69M
Shares

$403 Million
0.31% of portfolio
Wellington Management Group LLP Boston, MA

7.77M
Shares

$323 Million
0.07% of portfolio
State Street Corp Boston, MA

6.46M
Shares

$268 Million
0.01% of portfolio

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.91B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account